Literature DB >> 4692153

Parasympathetic suppression of manic symptoms by physostigmine.

D S Janowsky, K el-Yousef, J M Davis, H J Sekerke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4692153     DOI: 10.1001/archpsyc.1973.01750340072012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  23 in total

Review 1.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

2.  On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice.

Authors:  S Maayani; Y Egozi; I Pinchasi; M Sokolovsky
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

3.  Biochemistry of nervous dogs.

Authors:  D C DeLuca; O D Murphree; C Angel
Journal:  Pavlov J Biol Sci       Date:  1974-07

Review 4.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

5.  Associations of acetylcholinesterase activity with depression and anxiety symptoms among adolescents growing up near pesticide spray sites.

Authors:  Jose R Suarez-Lopez; Naomi Hood; José Suárez-Torres; Sheila Gahagan; Megan R Gunnar; Dolores López-Paredes
Journal:  Int J Hyg Environ Health       Date:  2019-06-13       Impact factor: 5.840

6.  Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.

Authors:  J Fritze; M Lanczik; E Sofic; M Struck; P Riederer
Journal:  J Psychiatry Neurosci       Date:  1995-01       Impact factor: 6.186

7.  Lethal effects of physostigmine plus lithium in rats.

Authors:  J R Samples; D S Janowsky; R Pechnick; L L Judd
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

8.  Physostigmine: effects on cognition and affect in normal subjects.

Authors:  K L Davis; L E Hollister; J Overall; A Johnson; K Train
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

9.  Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Authors:  D M Cannon; J K Klaver; S K Gandhi; G Solorio; S A Peck; K Erickson; N Akula; J Savitz; W C Eckelman; M L Furey; B J Sahakian; F J McMahon; W C Drevets
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

10.  Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.

Authors:  K D Murugaiah; O E Ukponmwan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.